Elser Financial Planning’s AbbVie ABBV Stock Holding History

Elser Financial Planning’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$678K	Buy	2,696 +67	+3%	+$14.4K	0.03%	61
2026 Q1	$555K	Buy	+2,629	New	+$583K	0.03%	69
2025 Q1	–	Sell	-2,612	Closed	-$464K	–	67
2024 Q4	$464K	Buy	+2,612	New	+$480K	0.03%	61
2024 Q3	–	Sell	-2,496	Closed	-$428K	–	63
2024 Q2	$428K	Buy	+2,496	New	+$413K	0.07%	62

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Elser Financial Planning's ABBV Position: Q2 2026 in Review

Elser Financial Planning increased its AbbVie (ABBV) stake by 2.5% in Q2 2026, buying an estimated $14.4K and bringing the position to 2,696 shares worth $678K. The position accounts for 0.03% of the portfolio, ranked #61.

Elser Financial Planning first reported a position in ABBV in Q2 2024 and has held it in 4 quarters since. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Elser Financial Planning held 2,696 shares of AbbVie worth $678K as of Q2 2026.
Elser Financial Planning bought 67 AbbVie shares in Q2 2026, an estimated $14.4K.
AbbVie made up 0.03% of Elser Financial Planning's portfolio in Q2 2026, its #61 holding.
Elser Financial Planning first reported a position in AbbVie in Q2 2024 and has held it in 4 quarters since.
4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Elser Financial Planning's 13F filing for Q2 2026, filed 14 Jul 2026.